Dr. Anic is a cardiologist/electrophysiologist serving as a head of an EP lab at Heart Center, University Hospital Split, Croatia. After finishing cardiology training in General Hospital Zadar, Croatia, he spent a year at Cleveland Clinic Atrial Fibrillation Innovation Center doing postdoctoral research fellowship.

He has multiyear experience with AF ablation, which is his primary interest of research. EP lab Split runs FIH type studies on a regular basis with a recent emphasis on development of pulsed field ablation for AF treatment.

Research interests also include ablation for ventricular arrhythmias, LAAC procedures and other stroke prevention strategies.

Elad Anter, MD, FACC, is an electrophysiologist, scientist, and innovator in the field of catheter ablation, specializing in catheter ablation of atrial fibrillation and ventricular tachycardia. Dr. Anter earned his undergraduate and medical degrees from Hebrew University in Jerusalem, Israel. He relocated to the United States for a postdoctoral research fellowship in molecular biology at Boston University and remained in Boston to complete his Internal Medicine residency at the Brigham and Women’s Hospital. He continued his training as a fellow in Cardiovascular Medicine at the University of Pennsylvania, Philadelphia, where he then completed a subspecialty training in Cardiac Electrophysiology. Dr. Anter was then recruited to the Beth Israel Deaconess Medical Center in Boston by the late Dr. Mark E. Josephson, a pioneer in the field of Cardiac Electrophysiology. Drs. Anter and Josephson worked closely together and have made significant contributions to the field of Cardiac Electrophysiology. During this tenure, Dr. Anter established a translational research laboratory that focuses on studying mechanisms of arrhythmias and translating this knowledge into innovations that improve patient care. This research laboratory has been pivotal in describing mechanisms of reentrant ventricular tachycardias, developing new mapping catheters and ablation technologies, that have since become standard of care. Dr. Anter dedicates significant time for teaching and mentoring fellows. “I’ve learned a lot from my own mentors who were instrumental in shaping me, and I share what I’ve learned with my mentees,” says Dr. Anter. He has published nearly 100 original articles in high-impact peer-reviewed medical journals, and frequently speaks at national and international medical meetings on his research and clinical interests.

Samuel J. Asirvatham, M.D., is a cardiac electrophysiology consultant in the Division of Heart Rhythm Services, Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Asirvatham holds joint appointments in the Division of Pediatric Cardiology, the Department of Physiology and Biomedical Engineering, and the Department of Anatomy. In addition, he serves as vice chair for innovation in the Department of Cardiovascular Medicine and medical director of the Electrophysiology Laboratory. He joined the staff of Mayo Clinic in 2000 and holds the academic rank of professor of medicine and pediatrics in Mayo Clinic College of Medicine and Science. Dr. Asirvatham is recognized with the distinction of the James M. and Lee S. Vann Professorship in Cardiovascular Diseases.

Dr. Asirvatham earned his M.B.B.S. and completed postgraduate work at Christian Medical College in Vellore, India. He held an internship at St. Luke’s–Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, and was chief resident at University of Wisconsin–Madison. He completed his clinical cardiac and electrophysiology training at the University of Oklahoma, Oklahoma City, and came to Mayo Clinic for a fellowship in electrophysiology/pacing.

One of Dr. Asirvatham’s primary goals is clinical research to improve patient care and quality of life. His most recent research and innovation interests include developing a new energy source that can eliminate heart rhythm disorders without creating heat, pain, or damage to normal tissues; alleviating neurocardiogenic syncope and treating hypertension by  modulating the autonomic nerves around the renal vessels; designing and creating tools to treat epilepsy and other central nervous system disorders by mapping and ablation of the central nervous system; and using ablation technology in the GI tract to treat diabetes.

Dr. Asirvatham is considered an expert in his field and is frequently invited to present on his work internationally. His research efforts are highly productive. He has completed more than a dozen grants and currently has several active federal, industry and foundation grants. His work has resulted in approximately 50 U.S patents and publication of over 500 peer-reviewed articles, abstracts, book chapters and commentaries in high-impact scientific journals. He also holds editorial responsibilities for a number of prominent scientific journals.

In addition to his clinical and research activities, Dr. Asirvatham serves as chair for education in the Division of Heart Rhythm Services, and he holds full faculty privileges in Clinical and Translational Science at Mayo Clinic Graduate School of Biomedical Sciences. He is program director for Mayo Clinic School of Graduate Medical Education and for the Clinical Cardiac Electrophysiology Training Program.

Throughout his career, Dr. Asirvatham has been the recipient of many awards. These include the Distinguished Teacher Award from the Heart Rhythm Society; Distinguished Educator Award from the American College of Cardiology; Mayo Clinic Awards for Individual Excellence and Partnership in Care and multiple Teacher of the Year awards. He was recognized with the Mayo Clinic Distinguished Educator Award in 2014 and Distinguished Inventor of the Year in 2020. Dr. Asirvatham has been elected as a fellow of the National Academy of Inventors.

My name is Elad Asher and I’m the director of the Intensive Cardiovascular Care Unit at Shaare Zedek Medical Center and in charge of the research unit as well. I’ve achieved my MD and MHA degrees at the Ben-Gurion University and did my interventional fellowship at the University Hospitals Cleveland Medical Center OH. My research focuses on myocardial infarction, platelets reactivity and atherosclerosis and I find special interest in intra-vascular imaging with OCT.

Prof. Behr is a recognized national and international expert and researcher in the field of arrhythmias. He is Professor in Cardiovascular Medicine and Honorary Consultant Cardiologist specializing in Electrophysiology at St George’s, University of London and St George’s Hospital, London.

He is also Consultant Cardiologist at the Mayo Clinic, London. He is Head of the Cardiology Research Centre and Director of the Cardiovascular Clinical Academic Group as St George’s where he leads a research group with interests in the causes and mechanisms underlying of sudden death, and its prevention. He co-leads the Inherited Cardiac Conditions clinic at St George’s, coordinating a multi-disciplinary team that provides a single one-stop service to families including children.

His research and clinical interests include:

• Families with unexplained sudden deaths, the Sudden Arrhythmic Death Syndrome (SADS) and Sudden Infant Death Syndrome (SIDS)
• Genetic risk for sudden death
• Ion channel diseases including the long QT and Brugada syndromes
• Drug-induced arrhythmia and QT prolongation
• Hypertrophic, dilated and arrhythmogenic right ventricular cardiomyopathies
• Management and treatment of arrhythmias and sudden death risk
• Ablation and complex device therapy

Dr Mauro Biffi is a Clinical Cardiologist and Director of Electrophysiology at Sant’Orsola-Malpighi Polyclinic, Bologna, IT. He is also a tutor at the Cardiology School of Bologna University and at several European training facilities.

His main areas of interest are arrhythmias and heart failure. Dr Biffi has participated in international clinical trials of pharmacological and non-pharmacological treatments (Dofetilide study of ventricular tachycardia suppression, B-LEFT study, ALSYNC trial, SOLVE CRT study, WRAP-IT trial, REVIVENT left ventricular reconstruction study, ADAPT-RESPONSE trial, ECG-BELT trial, ARTESIA study, ESC-EHRA EORP-AF registry and EV ICD Pivotal study).

He is focused on upstream prevention of complications associated to implantable cardiac devices therapy. Dr Biffi is the Clinical Coordinator of several multicenter studies (OPTIMIND Registry, ESSENTIAL Registry, DECODE Registry, CRT- Next randomized trial), and has co-authored more than 350 articles on indexed, peer-reviewed medical journals.

Prof. Lucas Boersma is a Cardiologist/Electrophysiologist at St. Antonius Hospital Nieuwegein and Professor at AMC Amsterdam/University of Amsterdam.

He was born in The Netherlands in 1965. He graduated from Medical School in 1996 at the University of Maastricht. In the same year he finished his PhD on Ventricular Tachycardia in the Rabbit Heart.

He completed his Cardiology specialty training in 2000 at St. Antonius Hospital in Nieuwegein, and his subspecialty training in Electrophysiology in 2001 at Hospital Clinic in Barcelona. Since then he is a staff member and Electrophysiologist at St.Antonius Hospital in The Netherlands. He was Head of the Cardiology Department from 2008-2016, as well as Medical Manager of the Cardiovascular Unit from 2011-2017.

He was chairman of the Netherlands Heart Rhythm Society from 2011-2016 and is now chairman of the Committee for Science& Innovation of the Netherlands Society of Cardiology NVVC. In between he was Treasurer of the Netherlands Cardiovascular Data Registration.

In 2017 he was appointed as a special Professor of Cardiology at the University of Amsterdam.

Prof. Boersma has published over a hundred articles in international, peer-reviewed journals, such as the New England Journal of Medicine, European Heart Journal, Journal of the American College of Cardiology, and Circulation. In addition, Prof. Boersma is Associate Editor at Europace and is a member of the editorial board of the European Heart Journal and the Heart Rhythm Journal. Prof. Boersma is a Fellow of the European Society of Cardiology and the European Heart Rhythm Association. In addition, Prof. Boersma is active either as a member or as chairman of multiple steering committees of international clinical studies.

Professor Haran Burri is an Electrophysiologist at the Cardiology Department of the University Hospital of Geneva (Switzerland), where he is director of the device program. After graduating from the University of Geneva in Geneva in 1992, he completed his specialization in Internal Medicine and in Cardiology before training in electrophysiology in Lyon (France). He obtained EHRA certification in cardiac pacing in 2006 and in electrophysiology in 2008. His research has focused on device therapy and catheter ablation, with over 250 publications. He has served as President of the Working Group of Pacing and Electrophysiology of the Swiss Society of Cardiology and is active in the European Heart Rhythm Association (EHRA) where he chaired the Education Committee and Scientific Program Committees, was Treasurer in 2020-2022 and Secretary for 2022-2024, and now serves as President-Elect for 2024-2026.

Riccardo Cappato is currently Director of the Arrhythmia and Electrophysiology Research Center at IRCCS Humanitas Research Center in Rozzano (Milan), Italy, and Director of the Arrhythmia and Electrophysiology II Center at Humanitas Gavazzeni Clinics, Bergamo, Italy. He is the current President of the European Cardiac Arrhythmia Society (ECAS). He has also been the Co-Director of the Europe AF Congress, held in London on an annual basis, during the 10 editions since 2007.

Dr. Cappato began his medical training at the University of Ferrara, completing it in 1989. He was a junior physician in the Department of Cardiology of the Arcispedale Santa Anna di Ferrara, Italy, where he also completed his internship and residency. Between 1993 and 2000, he was the Co-Director of the Electrophysiology Laboratory at Eppendorf University and St. Georg General Hospital, Hamburg, Germany. Between 2000 and 2015 he was the Director of the “Clinical Arrhythmia and EP Center” of Policlinico San Donato in Milan.

Dr. Larry A. Chinitz is the Benjamin and Coyle Family Professor of Medicine and Cardiac Electrophysiology, Director of Clinical Cardiac Electrophysiology and the NYU Heart Rhythm Center and Clinical Director, Leon H. Charney Division of Cardiology, New York University School of Medicine.

Dr. Chinitz graduated Phi Beta Kappa and summa cum laude with a B.A. in Biology from NYU and then received his M.D. with distinction in Internal Medicine and AOA from NYU School of Medicine.
He completed his internal medicine residency in the Bellevue/VA/NYU program, was named senior chief medical resident and then completed NYU Cardiology Fellowship.
Dr. Chinitz subsequently spent an additional year as a visiting fellow on the Electrophysiology service at Montefiore Medical Center.

Since joining the NYU faculty in 1982, Dr. Chinitz has played an enormously important role in furthering clinical, educational and research missions in Cardiology, the Department of Medicine and the NYU Medical Center.
He established the Clinical Cardiac Electrophysiology program and pioneered Radio Frequency Ablation. As a Center of Excellence for catheter-based treatment of Atrial Fibrillation, the Heart Rhythm Center Cardiac EP program provides top-quality cardiac rhythm management, cutting-edge research and world-renowned training programs. Unparalleled in the area the program has evolved into one of the premier international programs.
Dr. Chinitz has overseen the establishment of an increasingly robust research enterprise including the establishment of the Cardiovascular Genetics Program.
The EP faculty is involved in a large number of multi-center and local clinical trials, testing novel devices, pharmacotherapy and other innovative treatments for patients at risk of arrhythmias. These endeavors have resulted in increasing numbers of grants for research projects, publications and prominence on the national and international scene.

Dr. Chinitz have most recently been involved with the development of the leadless pacemaker. He was the first in the US to implant this device and currently serving as the national PI on the Micro AV device. This new leadless pacemaker is able to synchronize atrial mechanical function with ventricular pacing. By sensing atrial contraction, it can allow AV synchrony with a single leadless device in the ventricle. The headless system has been shown to have a 63% lower complication rate when compared to standard pacemakers.

He is currently involved in preclinical studies concentrating on the biophysics of catheters ablation.
Dr. Chinitz serves on the Cardiac and Vascular Institute leadership committee and has been integral to the marked expansion of cardiovascular medicine at NYU Langone, including the creation of new facilities for inpatient cardiology, NYU Heart Rhythm Center and Cardiovascular Genetics program.
As the current New York City American Heart Association (AHA) President, Dr. Chinitz focus is on Sudden Cardiac Death and reducing the unacceptable mortality rates in New York City.

Michal Cohen-Shelly is an electrical engineer working at Sheba Medical Center’s innovation arm, known as ARC.  She joined the team in October 2021 and serves as a leading data scientist for the hospital’s cardiology department.

Prior to joining ARC, she completed few years working with top clinicians at the Mayo Clinic in Rochester Minnesota as part of the cardiovascular artificial intelligence (AI) team.

In that capacity, she was involved in several high-impact research projects using electrocardiogram (ECG) and tabular data to accelerate AI-ECG research. Previously, she was a developer in private industry dealing with Big Data, business intelligence, science, and communications.

Her main interests include integrating patient needs and engineering as well as developing and leading innovative approaches to improve patient care.

Dr. Ziv Dadon, an accomplished cardiologist with fellowship credentials, specializing in Electrophysiology (McMaster University, Ontario with Royal College Accreditation). He completed his Internal Medicine and Cardiology residencies at the Hebrew University in Jerusalem (in 2018 and 2021, respectively), with a strong background in clinical practice, research, and multiple conference presentations. Among his fields of interest include genetic arrhythmia syndromes, sudden cardiac death, and AI-based clinical applications. Currently working at The Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Dr. Dadon is dedicated to ongoing professional development, contributing to both clinical and academic aspects of cardiac medicine.

Carlo de Asmundis M.D., Ph.D. is full professor in Cardiology at Vrije Universiteit Brussel, Chair of Heart Rhythm Management Center at Universitair Ziekenhuis Brussel and Director of Postgraduate program in Cardiac Electrophysiology and Pacing at Vrije Universiteit Brussel. Born and raised in Milan, graduated medical school in University Vita-Salute San Raffaele Hospital, Milan. Residency in Cardiology in Universitaʻ degli Studi di Milano. Electrophysiology and Pacing training fellowship at the UZ Brussel, under the direction and mentoring of prof. P. Brugada; he also concluded is Ph.D in Cardiovascular Physiopathology in Universitaʻ degli Studi di Milano. His academic carrier consisted of basic and mainly clinical research with several original publication in cardiac physiopathology, cardiac electrophysiology, focus on channelopathies, ventricular and supraventricular arrhythmias, neuro-cardiology together with his colleagues developed a cardiac arrhythmias hybrid program.

Dr. Luigi Di Biase is Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas.

Improving patient care is the heart of Dr. Di Biase’s mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase’s research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.

Dr. Di Biase, MD, PhD, FACC, FHRS, is a 2000 graduate (summa cum laude) of the medical school and a 2004 graduate (summa cum laude) of the cardiology residency program at the University of Bari, Bari, Italy. In 2006, he completed a second-level master degree in Electrophysiology and Pacing (summa cum laude) at the University of Insubria, Varese and Brescia, Italy.

In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship under the supervision of Dr. Andrea Natale at the Miller Family Heart & Vascular Institute at the Cleveland Clinic, Cleveland, Ohio. The following year, he accepted a position in cardiac electrophysiology at the University of Texas Medical School Branch in Galveston, Texas, where he continued to focus on his research projects Dr. Di Biase was appointed Assistant Professor in 2007 at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010. In 2009, Dr. Di Biase was appointed Adjunct Assistant Professor at the University of Texas at Austin, where he was promoted to Adjunct Associate Professor in 2012, the same year he joined Albert Einstein College of Medicine and Montefiore Medical Center with the title of Associate Professor, Department of Medicine (Cardiology).

In September 2014 Dr. Di Biase was appointed Section Head of Electrophysiology and Director of Arrhythmia Services at Einstein/Montefiore, while continuing to serve as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center. Thereafter Dr. Di Biase was promoted to the rank of Full Professor of Medicine, Department of Medicine (Cardiology).

Dr. Paul Friedman is a Professor of Medicine and the Norman Blane & Billie Jean Harty Chair, Mayo Clinic Department of Cardiovascular Medicine Honoring Robert L. Frye, M.D. at Mayo Clinic, Rochester, Minnesota. He is ABIM board certified in cardiovascular medicine and cardiac electrophysiology, and is an active participant in the MOC process.
Previously, Dr. Friedman served as Director of the Cardiac Implantable Device Lab, Mayo Clinic. He is a trained electrical engineer, with deep experience in innovation (> 40 patents issued, named Minnesota Top Inventor), and scientific research (> 250 scientific original publications). He is a committed educator, serving as a director for 5 national and international meetings, editor of 7 textbooks, and author of over 60 book chapters. He is a frequent visiting professor and lecturer at educational meetings.
Dr. Friedman received his BA in Plan II liberal arts and BS in Electrical Engineering from the University of Texas at Austin. He received his medical degree from Stanford University, and trained in internal medicine at the University of Washington, Seattle (internship) and Stanford University. He trained in cardiovascular medicine and cardiac electrophysiology at Mayo Clinic, Rochester, MN.
Interests:
•Atrial fibrillation management, including medications, remotemonitoring, medications, ablation, and left atrial appendageclosure
•Ventricular arrhythmia management (PVCs, VT)
•Medical and ablative management of SVTs
•Complex cardiac ablation, atrial and ventricular arrhythmia
•Cardiac device insertion, including leadless pacemaker, Hisbundle pacing, and subcutaneous defibrillator
•Interventional procedures (venoplasty, snaring) forpacemaker, ICD, and resynchronization device placement
•Percutaneous epicardial access for complex ablation andappendage closure
•Implantable device extraction
•Artificial intelligence in medicine
•Remote monitoring

Prof. Glikson graduated cardiology training at Sheba Medical Center, Israel and continued in a electrophysiology and pacing fellowship at the Mayo Clinic. He headed the Pacing and Electrophysiology Unit at Sheba Medical Center since 2002, and the Davidai Arrhythmia Center since 2010. He was appointed an associate professor of cardiology in 2006, full professorship in 2012. He is an adjunct professor of medicine at the Mayo Clinic College of Medicine and Science.

The Davidai Arrhythmia Center, developed from scratch over the years, is the first and most prominent arrhythmia center in Israel, which deals with all kinds of advanced EP procedures and has been the pioneer in CRT, epicardial ablations modern extraction techniques, and advanced VT ablation techniques. The Center, under the Prof. Glikson’s leadership, served as a tertiary referral center for complex arrhythmia and device cases and was the pioneer in bringing into the country new tools such as CRT implantation, modern extraction techniques, AF ablation using various techniques, VT ablations and more. The Center has a research lab that was built by donations raised by Prof.Glikson and maintained by competitive grants.

Many Israeli and international fellows underwent training at the Center under the guidance of Prof. Glikson, including fellows from Turkey, Greece, Romania and Brazil, some of whom were funded by competitive European grants to training centers.

As part of his role at the Heart Center, Prof. Glikson established the Mayo-Sheba collaboration program that brought together physicians and researchers from both institutions with collaborative meetings, several collaborative research projects, clinical collaboration and a fellowship program that brought several Israeli fellows from Sheba to train at Mayo for one to two years. He also initiated the Israel Heart Society – Mayo Clinic training program that brings prominent Israeli fellows to one or two year training in the USA.

Prof. Glikson’s main research interest is in cardiac pacing, defibrillation and CRT with more than 180 publications in the field. His list of publications includes 200 peer reviewed scientific research and review articles as well as 13 book chapters. He was an invited speaker at over 80 international meetings and abstract presenter of more than 370 abstracts. He was proctor of CRT, extraction and LAAO procedures in various international centers and serves as member on several editorial boards of EP journals (Europace, PACE, previously Heart Rhythm). Prof. Glikson was the initiator and principal investigator of several investigator–initiated research projects including Detect SVT, Rapture, and Raise CRT trials, in collaboration with Mayo Clinic researchers.

Over the years Prof. Glikson served as investigator and PI in more than 50 company initiated studies run at the Arrhythmia Center and at the Heart Institute and funded by companies. The Arrhythmia Center also serves as proctoring center for several medical device companies and Prof. Glikson himself often serves as a proctor of device companies in several places around the globe.

Prof. Glikson served as the secretary and the chair of the Israeli working group on pacing and electrophysiology. During his term as chairman, he established several successful national registries including the Israeli ICD registry that has produced numerous studies and publications. He was elected Secretary General of the Israel Heart Society (2004-2008) and as President of Israel Heart Society from 2015-2017.

Given his deep involvement and understanding of the Israeli health system, Prof. Glikson was recently nominated by the Israeli Minister of Health to the National Health Basket Committee which is the most important body that selects all the new medications and technologies to be funded by the government every year. This is a very busy and very prestigious task that expresses the acknowledgement of his thorough understanding and wide view of the Israeli health system.

Prof. Glikson is very well acknowledged in the European Heart Rhythm Association. He serves as the co-chair of the EHRA scientific program committee including the Europace 2015 meeting. Since June 2015 he is the chair of the scientific program committee of European Heart Rhythm Association was in charge of the Europace 2017 meeting. In his previous role on the scientific document committee Prof .Glikson coauthored several scientific and consensus European documents and was the senior author and leader on a consensus paper regarding use of left atrial occluder. He is currently a member of the ESC scientific program committee and the chair of a new consensus document on LAA occlusion. He was recently elected to serve as a board member (councilor) of the European Society of Cardiology 2018-2020.

Prof. Glikson serves as the co-president of the International Dead Sea Symposium, a prestigious international meeting in electrophysiology and one of the most important international scientific meetings in Israel.

Prof. Glikson has extensive knowledge and understanding of the Israeli health care system as well as of international cardiology societies and organizations. He has broad acceptance and close relationships with leaders of the American and European cardiology communities.

Over the years Prof. Glikson has raised more than two million dollars in donations and grants to the Arrhythmia Center, Heart Center and to the Israel Heart Society and raised company support for many academic activities, meetings and activities of the Israel Heart Society.

Dr. Ilan Goldenberg is a Professor of Medicine and Cardiology at the University of Rochester, New York. He is the Director of the Clinical Cardiovascular Research Center at the University of Rochester from 2018.

Professor Goldenberg has been involved in clinical research with cardiac arrhythmias for over 20 years, as documented by over 600 published papers. He has a substantial record of being the Principal Investigator of large clinical studies and multicenter trial. He is currently the principal investigator on more than 10 research grants from industry and Federal worth over $20 million, including a multicenter randomized clinical trial designed to evaluate the benefit of insertable cardiac monitoring to improve clinical outcomes in heart failure patients.

Professor Goldenberg was the PI of several multicenter clinical trials of device therapy, including the long-term MADIT-CRT trial (Goldenberg et al. NEJM 2014); the first prospective wearable cardioverter defibrillator (WEARIT-II) Registry  (Goldenberg et al. Circulation 2015); and the prospective Study of the Wearable Cardioverter Defibrillator in Advanced Heart-Failure Patients (SWIFT) trial (Goldenberg et al. JCE, 2017). Currently he is the PI of the prestigious AHA Strategically Focused  Research Network on Arrhythmias and Sudden Cardiac Death on Genomic and Precision Medicine Approaches to Evaluate Sex-Specific Sudden Cardiac Arrest Risk and Resuscitation Outcomes, focusing on sex-specific risk for sudden cardiac death in long-QT syndrome involving genomic studies, clinical trials, and database studies. He currently serves as PI and Co-PI of 4 NIH-funded projects, including serving as the Principal Investigator for the 1R61HL153001-01A1 clinical trial titled “Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM-REDUCE-AF Trial)”.

Professor Goldenberg also currently serves as the PI of several multicenter clinical trials of device therapy, conducted in the U.S. and in Europe, including the ASSERT-AF trial for early AF detection with the insertable cardiac monitoring for AF detection and the PRIMARY PREVENT VT trial that will evaluate for the first the role of prophylactic VT ablation at the time of ICD implant for primary prevention.

The Clinical Cardiovascular Research Center (CCRC) at the University of Rochester Medical Center, under the Directorship of Professor Goldenberg, is an internationally recognized research enterprise known for its many years of successfully conducting high impact cardiovascular research that has changed the practice of medicine and guideline recommendations in the field of device therapy for the prevention of sudden cardiac death and heart failure. Its innovative, dynamic and cross-functional collaboration with many leading medical centers and research departments throughout the world continues to foster pioneering research that brings forth new treatment paradigms aimed at improving the lives of our patients.

Gerhard Hindricks is a Professor of Medicine / Cardiology and the Medical Director of the Heart Center Leipzig. He is the Director of the Department of Electrophysiology of the Heart Center and the General Manager of the Leipzig Heart Institute (LHI). Gerhard Hindricks has a longstanding involvement in innovations and the development and clinical implementation of new technologies in the field of cardiovascular medicine and beyond. He has fundamental interest in design and implementation of novel process and diagnostic/therapeutic pathways in medicine. Moreover, Gerhard is Principal Investigator of multiple international, randomized and potentially guideline-relevant clinical trials. He has served the European Society of Cardiology in several leadership functions including President of European Heart Rhythm Association and is member of the ESC Digital Committee. Finally, he has published almost 800 peer-reviewed articles in the leading journals of the world and is the Editor-in-Chief of the Europace Journal, one of the top international journals in the field of cardiac arrhythmias.

Josef Kautzner is a Czech-born cardiologist (1957) and a graduate of Charles University Medical School I in Prague (1983 cum laude). He obtained a substantial part of his training at the Department of Medicine II, Charles University General Hospital in Prague, and during stays in London or Houston. He has been working at the Institute for Clinical and Experimental Medicine in Prague since 1996 (head of the department of cardiology since 2001 and chairman of the Scientific Council since 2016).

He became a Professor of Medicine and Board approved cardiologist in 2005. His clinical interest is focused mainly on cardiac arrhythmias and cardiac resynchronization therapy, electrocardiography, and imaging.

He is an author of 4 books, author or co-author of more than 400 scientific papers, and many book chapters. His H index in January 2024 reached 70 with 30414 quotations.

Dr Keene is a consultant cardiologist treating patients at Royal Free London Foundation NHS Trust. He is involved in all clinical aspects of inpatient and outpatient general cardiology, but his clinical focus is in cardiac electrophysiology and complex devices.

Dr Keene graduated from the University of Manchester in 2009 having received commendations for all his special study modules. In 2013, he was appointed a prestigious National Institute for Health and Care Research academic clinical fellow cardiology fellowship.
He was also awarded the British Heart Foundation clinical research fellow training fellowship to address novel issues in implantable cardiac devices leading to award of his PhD. He completed his general cardiology training and was appointed advanced clinical training fellow in electrophysiology and devices.

He has developed highly specialized skills and is highly regarded internationally for being a high-volume implanter, proctor, researcher and educator in this field.

Prof Pier Lambiase, PhD, FRCP, BMBCh, is a consultant cardiologist specialising in the treatment of heart rhythm disorders and pacemaker implantation. He graduated from Oxford University in 1992 and trained in cardiology at St Thomas’ and Hammersmith Hospitals. Following completion of a PhD in 2002, he undertook higher specialist training in electrophysiology and became a consultant cardiologist and senior lecturer at the Heart Hospital, UCL in 2006 and was promoted to reader in cardiology in 2012.

He was the British Cardiac Society Young Investigator in 2002 and finalist in the North American Pacing & Electrophysiology Society Young Investigator competition in the same year. He was awarded the British Cardiovascular Society Early Career Award for his research in 2015 and elected Fellow of the Heart Rhythm Society the same year.

Prof Lambiase conducts research into the causes and treatment of inherited rhythm disturbances, sudden arrhythmic death syndrome and family screening. He has the co-written Heart Rhythm UK Guidelines on genetic testing and the management of these conditions and published more than 100 peer-reviewed papers and book chapters in cardiology. He is an editor of the Oxford Handbook of Inherited Cardiovascular Disease and the panel lead for the Royal College of Physicians Map of Medicine pathways in arrhythmia management. He is the British Heart Rhythm Society Chair for Research.

Prof Pier Lambiase is a section editor for Arrhythmia Risk Stratification for AER.

Randy A. Lieberman, MD FACC is a Professor of Medicine at Wayne State University School of Medicine, Detroit Michigan He completed fellowships in cardiology and electrophysiology at Case Western Reserve University , and  specialty training in pediatric congenital arrhythmia at University of South Carolina. He has previously been a faculty member at Case Western Reserve University and University of California-Berkley.

Dr. Lieberman joined the Wayne State University Faculty/Detroit Medical Center in 1999. He specializes in the diagnosis and treatment of cardiac rhythm disorders (arrhythmias) and heart failure and has a special interest in the treatment of atrial fibrillation and heart failure. He is a world-recognized expert in cardiac ablation, Cardiac Implantable Electronic Devices (CIEDs), Cardiac Resynchronization Therapy (CRT) and the precise placement of cardiac pacing electrodes within the heart. A sought-after lecturer and educator, Dr. Lieberman has been the recipient of many awards including Wayne State University School of Medicine  Distinguished Educator Award  and Department of Cardiology Teacher of the Year award.

Dr. Lieberman has been involved with development of novel therapies for patients with cardiac arrhythmia disorders, has written several books and a multiplicity of manuscripts involving diverse topics in the field electrophysiology.

He graduated from The University of Pittsburgh School of Medicine in 1983, after which he completed his internship and residency training for internal medicine at The Ohio State University Wexner Medical Center in Columbus Ohio.

He stayed at O.S.U. for his cardiology and electrophysiology training to become the Director of Cardiac Rhythm Device Services.

His academic career advanced and he achieved promotion to Professor of Medicine. After 30 years at O.S.U., he left to join the New York University Langone Medical Center. He was brought on at the rank of Professor of Medicine and again was charged with managing the cardiac device service. In 2017, Dr. Love moved to Baltimore Maryland where he is now part of the electrophysiology group at Johns Hopkins Hospital, once again at the rank of Professor of Medicine. He is also Director of Cardiac Rhythm Device Services there as well.

Dr. Love is best known for his work in lead extraction of chronically implanted pacing and defibrillator leads/wires and has been performing these procedures since 1988. As one of the pioneers and top lead extraction experts in the world, in 1994 he was the first cardiologist to use a laser to extract a pacemaker wire. He has participated in numerous clinical trials including new rate response sensor technologies, heart failure therapy devices, heart failure monitoring devices, and new lead extraction devices (“first in man” for the TightRail). He regularly consults with cardiac rhythm device companies, extraction device companies and other biomedical and startup companies regarding the design of new devices and health care technologies. He has presented new technologies to the United States Food and Drug Agency on multiple occasions.
Dr. Love has given hundreds of invited lectures and presented abstracts both nationally and internationally.

Dr. Love is board certified in Internal Medicine, Cardiovascular Medicine, and Clinical Cardiac Electrophysiology. He is also board certified as a Cardiac Device Specialist.
He took the pacemaker competency examination in 1991, achieving the highest score on the exam that year.

In 1995 he was then appointed to the examination development committee of the International Board of Heart Rhythm Examiners (formerly NASPExAM, Inc), and since 2004 has served as Chair of the Pacing and Defibrillation Competency Exam as well as President and Chair of the Board of Directors for the organization.

Dr. Love has implanted over 9000 devices and has removed in excess of 3000 pacing and defibrillator leads.

Prof. David Luria specializes in the field of cardiology. He engaged in the treatment of various types of arrhythmias, in particular using a modern method – ablation. it conducts effective treatment for atrial fibrillation, which has resorted to the isolation of veins. Also, Prof. Luria implant various types of defibrillators and other devices that support the heart.

In St. Petersburg, he received his education at the Medical University. His first training was held in Soroka Hospital, where it worked in the field of relief and cure of Internal Medicine. Later, in Jerusalem, he held another training, which determined his future activities: in the Center of Shaare Zedek been treating ailments of the heart muscle. More details to delve into the study of arrhythmia specialist could during an internship in the US.

Specialization: cardiology, electrophysiology, treatment of all types of cardiac arrhythmia, mini-invasive procedure of radiofrequency ablation, pacemaker implantation and extraction, biventricular devices, defibrillation electrodes, endovascular occlusion of the left anuria of Watchman, innovative therapy for isolation of pulmonary veins in atrial fibrillation.

Petr Neuzil, MD, PhD is Professor of Cardiology and Head of the Department of Cardiology at the Na Homolce Hospital of Prague in Czech Republic, Chairman of the Czech working group on Arrhythmias and Cardiac Pacing, and Member of Czech Society of Cardiology and Member of EHRA.

Prof. Neuzil received his medical degree and doctorate at the School of Medicine, Charles University in Prague, Czech Republic, and continued his training there in the Internal Medicine and Cardiology.
Almost all professional life has given to working at hospital Na Homolce in Prague. He has main professional interests in invasive cardiology and Electrophysiology.

He passed out postgraduate courses: Permanent pacing electrophysiology, University of Lund, Sweden in 1992, Cardiology for young cardiologists, Herz Zentrum, Bad Krozingen, Germany 1996, 1998.
He was an Associate Professor of Cardiology in 2008 in Prague and after three years he was Professor of Cardiology.

Prof. Neuzil is also Head of the department clinical trial at the Na Homolce hospital. In this department are working on 50 trials at present. Among these clinical trials are also international multicenter studies such as: AVEIR VR + DR, SPHERE PVI + RF/PF, PULSE EU, APPLAUSE, CORCINCH-HF, PFCA/PFA, EUREKA, CS-08 and more.

Prof. Neuzil has authored or co-authored in 6 chapters (monographs), 188 articles (Czech medical journals), 47 articles (international journals), 207 abstracts (Czech journals), 191 abstracts (international and Czech journals).

Brian Olshansky, MD, FACC, FAHA, FHRS, FESC, is an Emeritus Professor of Medicine at the University of Iowa Carver College of Medicine and is an internationally known electrophysiologist. He directed two Clinical Cardiac Electrophysiology and the Fellowship Training Programs. Dr. Olshansky is recognized globally for expertise syncope, arrhythmias in athletes, arrhythmia mechanisms, autonomic cardiovascular control, artificial intelligence, multi-center randomized clinical arrhythmia trials, supplements, placebo response, and treatment of atrial and ventricular arrhythmias using device, ablation and drugs. He is a practicing clinical cardiac electrophysiologist. He has been involved in multiple clinical trials. Dr. Olshansky is a member of numerous editorial boards, lectures internationally and is a mentor to a multitude of trainees throughout the world. He published several books, >380 peer reviewed manuscripts and is an editor of the ventricular tachycardia section of ESC Cardiovascular text. He is an editor of EPSAP.  Dr. Olshansky has trained many electrophysiologists at the University of Iowa and Loyola University.  He is a critical reviewer and innovator.

Dr. Packer is internationally known in cardiac electrophysiology. He is currently at the Intermountain Medical Center. He was the past John M. Nasseff, Sr., Professor in Cardiovascular Diseases in the Division of Cardiac Electrophysiology, at Mayo Clinic Rochester. and the Director of the Translational Electrophysiology Research Laboratory.  He received the MD degree at the University of Utah and completed an internship, residency and fellowship at Duke University, where he was on staff before coming to Mayo. His honors and awards include the ACC 2019 Distinguished Scientist Award (Translational) (2019), the Distinguished Service Award from Brigham Young University, the Haskel Schiff Award in Internal Medicine from Duke University, the Eric Prystowsky Advocate for Patients Award, and a variety of Visiting Professorship awards.
Dr. Packer is active in the Heart Rhythm Society where he is a past president and member of the Board of Trustees. He is also active in the American Heart Association and the American College of Cardiology. He has served/currently serves on editorial boards for the Circulation Arrhythmia & Electrophysiology, American Heart Journal, the Journal of Cardiovascular Electrophysiology, Heart Rhythm journal, and the (EP) Journal of the American College of Cardiology. He also has served on multiple National Heart, Lung, and Blood Institute work groups on atrial fibrillation, ablation and planning for future NIH studies.
Dr. Packer has been an active teacher and mentor, and lectures widely on cardiac arrhythmias. He has written or co-authored more than 419 publications and 644 abstracts. He has lectured extensively in national and international meetings, giving over 1,872 invited lectures in 41 countries.  He has served on the executive committee of a number of NIH multicenter randomized clinical trials, Including the MUSTT, SCD-HeFT, and HAT Trials.  Dr. Packer is also the International Principal Investigator of the recently reported NIH CABANA Trial. In this capacity he led the consortium of centers directing the trial. He is the PI of the Thermedical VT Needle Electrode study, and on the Executive Committee of the LESS VT Study.
Dr. Packer has served as a Clinician Scientist.  His translational work focuses on the mechanisms and ablation of atrial fibrillation and other cardiac arrhythmias, autologous fibroblast modulation of electrical impulse propagation in the heart, and the development of carbon particle catheter-free ablation of arrhythmias.  His clinical work investigates 4/5 dimensional integrated image-guided ablation, and the development of new energy sources for the modification of cardiac tissue.   His work has been funded in part by private foundations, the American Heart Association, and the NIH.  A key part of his research is the development of the US Catheter Free Particle Therapy Ablation Program. He is also the PI of the Extracorporeal Particle Therapy Ablation Using Proton and Carbon Beams, that is currently under way. Dr. Packer holds US and European patents in the development of intracardiac ultrasound and 4/5D imaging, and particle therapy ablation.

Dr Ivo Roca-Luque is a cardiologist at the University of Barcelona – Institut Clínic Cardiovascular (ICCV) in Barcelona, Spain

Dr. Melvin Scheinman, one of the pioneers of cardiac electrophysiology (the study of the heart’s electrical activity), was the first to perform catheter ablation on humans. His team was instrumental in developing radiofrequency energy applications for cardiac arrhythmias. Scheinman and his colleagues also developed techniques for better understanding the mechanisms and treatment of cardiac rhythm disorders in patients with inappropriate sinus tachycardia – a condition in which resting heart rate is abnormally high – and to cure patients with automatic junctional tachycardia, in which one area of the heart is leading to a too-fast beat.

Scheinman currently directs the cardiac genetic arrhythmia program, which is devoted to discovering new genes related to heart rhythm disorders.

Scheinman grew up in Brooklyn, New York, and earned an undergraduate degree at Johns Hopkins University, where he graduated first in his class. His medical education included Albert Einstein College of Medicine, residency training at the University of North Carolina at Chapel Hill and cardiology training at UCSF Medical Center.

Professor of Medicine (Cardiology), Radiology & Bioengineering
Director & Chief, UCLA Cardiovascular & Interventional Programs
Director, UCLA Cardiac Arrhythmia Center & EP Programs

Dr. Shivkumar is an interventional physician scientist serving as the founding director of the UCLA Cardiac Arrhythmia Center & EP Programs (since its establishment in 2002) and as the director & chief of UCLA’s Cardiovascular and Interventional Programs since 2013.

He is currently a Professor in the Departments of Medicine (Cardiology), Radiology and Bioengineering. He leads a team that provides state of the art interventional clinical care and has developed several innovative therapies for the non-pharmacological management of cardiac arrhythmias, other cardiac diseases, and interventions beyond the heart.

He has a long track record of securing competitive extramural grants, publishing highly cited research papers, and has developed intellectual property at UCLA that has been commercialized.

He has been elected as a member of the prestigious honor societies including-American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and Association of University Cardiologists (AUC). He was also elected as an honorary fellow of the Royal College of Physicians, London (FRCP). He was named as the Editor-in-Chief of the Journal of the American College of Cardiology: Clinical Electrophysiology in 2020. He served as the president of the International Society of Autonomic Neuroscience (2019-2022) and his scientific focus is to develop neuroscientific therapies for various organ diseases (the concept of- ‘Internet of the Human Body’). He also founded the Amara-Yad project an open access knowledge portal for medical education.

Prof. Dr. Christoph Starck is a Senior Consultant Cardiac Surgeon at the German Heart Center in Berlin, Germany. He covers the complete cardiac surgical spectrum & has a special focus on arrhythmia & cardiac device surgery. Prof. Starck is renowned for his large clinical experience in transvenous lead extraction procedures, conducts several lead extraction workshops annually & is the founder of the International Lead Extraction Expert Meeting (ILEEM), established in 2012. His research activities in the field of lead extraction procedures focus on improving patient safety as well as extraction tools and techniques. He has further research projects focusing on the development of innovative technologies in assist device therapy, as well as the optimization of extracorporeal circulation technologies & techniques. He is Fellow Member of the European Heart Rhythm Association (FEHRA) & member of the following societies: EACTS, ESC, DGTHG & SGHC.

Harikrishna Tandri, MBBS, is a Professor of Medicine and a clinician-educator in the Division of Cardiovascular Medicine within the Department of Medicine at Vanderbilt University Medical Center and Director of the Cardiac Arrhythmia program. He specializes in the diagnosis and management of ventricular arrhythmias in patients with inherited heart disease.

He is an internationally recognized expert in arrhythmogenic right ventricular cardiomyopathy and in epicardial ventricular tachycardia ablation procedures. In addition to this, he has been involved in innovating new methods and devices for treating arrhythmias while reducing the pain of cardiac defibrillation, and for rapidly cooling vulnerable brain and spinal tissue to protect them during cardiac arrest. Dr. Tandri studied medicine at the University of Health Sciences in India and the Royal College of Physicians in England.

He completed residencies in internal medicine and cardiology in India, England, and at the Harbor Hospital Center in Baltimore. He then pursued fellowships in ARVD research and electrophysiology at the Johns Hopkins University School of Medicine. Dr. Tandri has received numerous awards, including BME IDEA of the Year for his Rapid Hypothermia Device. He has published nearly 200 peer-reviewed articles and book chapters, many on the diagnosis and treatment of arrhythmias and ARVD.

Dr. Valderrábano came to Houston from Los Angeles where he was director of the Implanted Devices Clinic at the UCLA Cardiac Arrhythmia Center and assistant professor of medicine at UCLA Medical Center.

Dr. Valderrábano received his medical degree from Universidad Autónoma de Madrid (UAM) School of Medicine in Madrid, Spain, and internal medicine training at UCLA. He completed his cardiology and electrophysiology training at Cedars-Sinai Medical Center in Los Angeles, where he was chief cardiology fellow. He then joined the faculty at the David Geffen School of Medicine at UCLA.

Dr. Pugazhendhi Vijayaraman obtained his medical degree from Madurai Medical College and completed his residency at Jacobi Medical Center. He completed his fellowships in cardiovascular diseases and clinical cardiac electrophysiology at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center.

Dr. Vijayaraman specialises in cardiac electrophysiology, cardiac ablations, cardiac device implantation, His bundle pacing and Watchman. His clinical interests include electrophysiology. He is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease and clinical cardiac electrophysiology.

Alphons Vincent, MD, is currently Medical Director for the Cardiac Rhythm Management division of Medtronic in Western Europe. He is with Medtronic for 33 years and held several positions in marketing, business, clinicals, education and medical affairs.

His experience includes positions in Vitatron, a pacemaker company within the Medtronic corporation, Cardiac Surgery (heart valves), Subcutaneous Diagnostics and Monitoring (Reveal) and Cardiac Rhythm Management. He is a graduate (MD) of the Medical School at the University of Nijmegen (The Netherlands) and holds bachelor’s degrees in management information systems and Economics at the University of Tilburg (The Netherlands).

In his current role he is responsible for physician advisory boards, scientific and educational symposia, clinical evidence strategy, the Office of Medical Affairs and professional relations with the medical societies and associations. He plays a coordinating role in managing the relationships with key opinion leaders in Europe.

Dr. Viskin was born in Mexico and lives in Tel Aviv, Israel. He received his medical degree from the Sackler School of Medicine, Tel Aviv University, completed his residencies at the Sourasky Tel Aviv Medical Center and was a cardiology fellow at the University of California, San Francisco, CA.
Currently, Dr. Viskin is the Chaim Sheba Chair of Cardiology, Tel Aviv University.

During the last two decades, Dr. Viskin served as Associate Editor for Europace, Heart Rhythm and until recently, Circulation. He has been an Editorial Board member of Heart Rhythm and has reviewed nearly 400 manuscripts for the Journal. Dr. Vaskin is the new editor-in-chief of Heart Rhythm, the official journal of the HRS, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society.

Dr. Viskin’s research has focused on ventricular arrhythmias, particularly polymorphic ventricular tachyarrhythmias related to the long QT syndromes, idiopathic ventricular fibrillation, Brugada syndrome and Purkinje-related polymorphic ventricular tachycardia. He has published 250 peer-reviewed articles. For his scientific achievements, Dr. Viskin was awarded the Pioneer in Cardiac Pacing and Electrophysiology award by the HRS in 2022.